Logo image of EXPO

EXPONENT INC (EXPO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EXPO - US30214U1025 - Common Stock

74.59 USD
-0.43 (-0.57%)
Last: 1/9/2026, 8:00:01 PM
74.59 USD
0 (0%)
After Hours: 1/9/2026, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXPO. EXPO was compared to 86 industry peers in the Professional Services industry. Both the health and profitability get an excellent rating, making EXPO a very profitable company, without any liquidiy or solvency issues. EXPO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year EXPO was profitable.
In the past year EXPO had a positive cash flow from operations.
EXPO had positive earnings in each of the past 5 years.
EXPO had a positive operating cash flow in each of the past 5 years.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

EXPO has a Return On Assets of 13.77%. This is amongst the best in the industry. EXPO outperforms 90.70% of its industry peers.
EXPO's Return On Equity of 26.02% is fine compared to the rest of the industry. EXPO outperforms 79.07% of its industry peers.
EXPO has a better Return On Invested Capital (14.36%) than 80.23% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXPO is significantly above the industry average of 11.86%.
The 3 year average ROIC (18.56%) for EXPO is well above the current ROIC(14.36%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROIC 14.36%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

EXPO's Profit Margin of 18.35% is amongst the best of the industry. EXPO outperforms 86.05% of its industry peers.
In the last couple of years the Profit Margin of EXPO has remained more or less at the same level.
EXPO has a better Operating Margin (20.64%) than 87.21% of its industry peers.
EXPO's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 92.96%, EXPO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of EXPO has remained more or less at the same level.
Industry RankSector Rank
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EXPO is creating value.
EXPO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EXPO has been reduced compared to 5 years ago.
EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 9.15 indicates that EXPO is not in any danger for bankruptcy at the moment.
EXPO's Altman-Z score of 9.15 is amongst the best of the industry. EXPO outperforms 96.51% of its industry peers.
There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.15
ROIC/WACC1.63
WACC8.83%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

EXPO has a Current Ratio of 2.69. This indicates that EXPO is financially healthy and has no problem in meeting its short term obligations.
EXPO has a Current ratio of 2.69. This is amongst the best in the industry. EXPO outperforms 84.88% of its industry peers.
EXPO has a Quick Ratio of 2.69. This indicates that EXPO is financially healthy and has no problem in meeting its short term obligations.
EXPO's Quick ratio of 2.69 is amongst the best of the industry. EXPO outperforms 84.88% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

The earnings per share for EXPO have decreased by -0.97% in the last year.
Measured over the past 5 years, EXPO shows a small growth in Earnings Per Share. The EPS has been growing by 6.74% on average per year.
EXPO shows a small growth in Revenue. In the last year, the Revenue has grown by 4.90%.
Measured over the past years, EXPO shows a small growth in Revenue. The Revenue has been growing by 6.01% on average per year.
EPS 1Y (TTM)-0.97%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%10%
Revenue 1Y (TTM)4.9%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%9.58%

3.2 Future

EXPO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.06% yearly.
Based on estimates for the next years, EXPO will show a small growth in Revenue. The Revenue will grow by 6.32% on average per year.
EPS Next Y-1.05%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue Next Year4.12%
Revenue Next 2Y5.99%
Revenue Next 3Y6.32%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.39, EXPO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of EXPO indicates a slightly more expensive valuation: EXPO is more expensive than 60.47% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of EXPO to the average of the S&P500 Index (27.19), we can say EXPO is valued slightly more expensively.
EXPO is valuated quite expensively with a Price/Forward Earnings ratio of 32.79.
61.63% of the companies in the same industry are cheaper than EXPO, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.88. EXPO is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 36.39
Fwd PE 32.79
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXPO is valued a bit more expensive than the industry average as 62.79% of the companies are valued more cheaply.
EXPO's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 30.28
EV/EBITDA 27.63
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The excellent profitability rating of EXPO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)5.4
EPS Next 2Y3.58%
EPS Next 3Y5.06%

5

5. Dividend

5.1 Amount

EXPO has a Yearly Dividend Yield of 1.73%.
EXPO's Dividend Yield is rather good when compared to the industry average which is at 1.54. EXPO pays more dividend than 80.23% of the companies in the same industry.
EXPO's Dividend Yield is comparable with the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 1.73%

5.2 History

EXPO has been paying a dividend for at least 10 years, so it has a reliable track record.
EXPO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years11
Div Non Decr Years11
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

EXPO pays out 58.07% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.07%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

EXPONENT INC

NASDAQ:EXPO (1/9/2026, 8:00:01 PM)

After market: 74.59 0 (0%)

74.59

-0.43 (-0.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)01-29 2026-01-29/amc
Inst Owners97.74%
Inst Owner Change-0.01%
Ins Owners0.97%
Ins Owner Change0.91%
Market Cap3.72B
Revenue(TTM)571.36M
Net Income(TTM)104.84M
Analysts82.22
Price Target87.21 (16.92%)
Short Float %5.08%
Short Ratio5.9
Dividend
Industry RankSector Rank
Dividend Yield 1.73%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP58.07%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.88%
Min EPS beat(2)3.34%
Max EPS beat(2)6.42%
EPS beat(4)4
Avg EPS beat(4)6.95%
Min EPS beat(4)3.34%
Max EPS beat(4)11.81%
EPS beat(8)7
Avg EPS beat(8)7.03%
EPS beat(12)8
Avg EPS beat(12)4.77%
EPS beat(16)12
Avg EPS beat(16)5.48%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)2.1%
Revenue beat(4)3
Avg Revenue beat(4)0.77%
Min Revenue beat(4)-0.43%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)0.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.01%
PT rev (3m)-2.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.77%
EPS NY rev (1m)0%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 36.39
Fwd PE 32.79
P/S 6.51
P/FCF 30.28
P/OCF 28.15
P/B 9.24
P/tB 9.44
EV/EBITDA 27.63
EPS(TTM)2.05
EY2.75%
EPS(NY)2.27
Fwd EY3.05%
FCF(TTM)2.46
FCFY3.3%
OCF(TTM)2.65
OCFY3.55%
SpS11.45
BVpS8.07
TBVpS7.9
PEG (NY)N/A
PEG (5Y)5.4
Graham Number19.3
Profitability
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROCE 19.43%
ROIC 14.36%
ROICexc 21.82%
ROICexgc 22.3%
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
FCFM 21.51%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
ROICexc(3y)30.54%
ROICexc(5y)30.82%
ROICexgc(3y)31.45%
ROICexgc(5y)31.86%
ROCE(3y)25.12%
ROCE(5y)22.78%
ROICexgc growth 3Y-10.75%
ROICexgc growth 5Y-4.18%
ROICexc growth 3Y-10.36%
ROICexc growth 5Y-3.84%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.68%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 103.34%
Profit Quality 117.23%
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 9.15
F-Score6
WACC8.83%
ROIC/WACC1.63
Cap/Depr(3y)141.73%
Cap/Depr(5y)120.6%
Cap/Sales(3y)2.21%
Cap/Sales(5y)1.87%
Profit Quality(3y)105.59%
Profit Quality(5y)110.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.97%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%10%
EPS Next Y-1.05%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue 1Y (TTM)4.9%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%9.58%
Revenue Next Year4.12%
Revenue Next 2Y5.99%
Revenue Next 3Y6.32%
Revenue Next 5YN/A
EBIT growth 1Y6.51%
EBIT growth 3Y3.15%
EBIT growth 5Y7.03%
EBIT Next Year24.48%
EBIT Next 3Y13.64%
EBIT Next 5YN/A
FCF growth 1Y55.07%
FCF growth 3Y5.33%
FCF growth 5Y10.11%
OCF growth 1Y36.83%
OCF growth 3Y5.08%
OCF growth 5Y5.99%

EXPONENT INC / EXPO FAQ

What is the fundamental rating for EXPO stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPO.


What is the valuation status of EXPONENT INC (EXPO) stock?

ChartMill assigns a valuation rating of 1 / 10 to EXPONENT INC (EXPO). This can be considered as Overvalued.


Can you provide the profitability details for EXPONENT INC?

EXPONENT INC (EXPO) has a profitability rating of 9 / 10.


What is the valuation of EXPONENT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EXPONENT INC (EXPO) is 36.39 and the Price/Book (PB) ratio is 9.24.


How sustainable is the dividend of EXPONENT INC (EXPO) stock?

The dividend rating of EXPONENT INC (EXPO) is 5 / 10 and the dividend payout ratio is 58.07%.